Ligands of Immunopharmacology

QS-21, an immunostimulatory saponin, could be used as a potent vaccine adjuvant. QS-21 stimulates Th2 humoral and Th1 cell-mediated immune responses through action on antigen presenting cells (APCs) and T cells. QS-21 can activate the NLRP3

R110 is a potent, competitive inhibitor of macrophage migration inhibitory factor 2 (MIF2) tautomerase with an IC 50 of 15 μM. R110 has the potential for the research of cancer diseasesForm:SolidIC50&amp Target:IC50: 15 μM (MIF2)

R110 is a potent, competitive inhibitor of macrophage migration inhibitory factor 2 (MIF2) tautomerase with an IC 50 of 15 μM. R110 has the potential for the research of cancer diseasesForm:SolidIC50&amp Target:IC50: 15 μM (MIF2)

R110 is a potent, competitive inhibitor of macrophage migration inhibitory factor 2 (MIF2) tautomerase with an IC 50 of 15 μM. R110 has the potential for the research of cancer diseasesForm:SolidIC50&amp Target:IC50: 15 μM (MIF2)

RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase.In VitroRDR 02308 (0-10 μM 1 h) inhibits LPS (HY-D1056)-mediated IL-6 production in RAW264.7 cells. MCE has not independently confirmed the accuracy of these methods.

RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase.In VitroRDR 02308 (0-10 μM 1 h) inhibits LPS (HY-D1056)-mediated IL-6 production in RAW264.7 cells. MCE has not independently confirmed the accuracy of these methods.

RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase.In VitroRDR 02308 (0-10 μM 1 h) inhibits LPS (HY-D1056)-mediated IL-6 production in RAW264.7 cells. MCE has not independently confirmed the accuracy of these methods.

RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase.In VitroRDR 02308 (0-10 μM 1 h) inhibits LPS (HY-D1056)-mediated IL-6 production in RAW264.7 cells. MCE has not independently confirmed the accuracy of these methods.

RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase.In VitroRDR 02308 (0-10 μM 1 h) inhibits LPS (HY-D1056)-mediated IL-6 production in RAW264.7 cells. MCE has not independently confirmed the accuracy of these methods.

RDR 03785 is a covalent MIF inhibitor with an IC 50 of 0.36 μM.Form:Solid

RDR 03785 is a covalent MIF inhibitor with an IC 50 of 0.36 μM.Form:Solid

RDR 03785 is a covalent MIF inhibitor with an IC 50 of 0.36 μM.Form:Solid